Should herbal medicines be regulated as drugs?

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 3, 2008, Pages 393-395

  McGuffin, M ^a  

^a American Herbal Products Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRINGENT AGENT; ATORVASTATIN; DIGOXIN; EMOLLIENT AGENT; EPHEDRA EXTRACT; HAMAMELIS EXTRACT; HERBACEOUS AGENT; ISPAGULA; LAXATIVE; MORPHINE; NON PRESCRIPTION DRUG; SENNOSIDE;

DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG FATALITY; DRUG LEGISLATION; DRUG PURITY; DRUG QUALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HERBAL MEDICINE; HUMAN; POLICY; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

ANIMALS; DRUG AND NARCOTIC CONTROL; HUMANS; MEDICINE, HERBAL; PHARMACEUTICAL PREPARATIONS; PLANT PREPARATIONS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 39449084058     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100480     Document Type: Short Survey

References (19)

1. Title 21 United States Code, Section 343(r)(6)(B) [21 U.S.C. 343(r)(6)(B)].
2. 21 U.S.C. 343(r)(6)(C).
3. 21 U.S.C. 342(f)(1)(A).
4. U.S. Court of Appeals Tenth Circuit; 17 August 2006; No. 05-1541.
5. U.S. Court of Appeals Third Circuit; 7 February 2006; No. 04-4481.
6. 21 U.S.C. 342(f)(1)(C).
7. Title 21 Code of Federal Regulations, Section 190.6(b)(4) [21 CFR 190.6(b)(4)].
8. 110th Congress; S.A. 1022 to S. 1082; 2 May 2007.
9. Stupak, B., chairman, Oversight and Investigations Subcommittee, US House of Representatives Committee on Energy and Commerce. FDA Foreign Drug Inspection Program: A System at Risk 〈http://energycommerce.house.gov/ Subcommittees/OI-Stupak/110107.OI.FDA.drugsafety.pdf〉 (1 November 2007).
10. US Food and Drug Administration. Adulterated pet foods recalled by the FDA 〈http://www.fda.gov/ora/fed_state/recalls/pet_food.pdf〉 (2007).
11. US Food and Drug Administration. FDA Advises Consumers to Avoid Toothpaste from China Containing Harmful Chemical 〈http://www.fda.gov/bbs/ topics/NEWS/2007/NEW01646.html〉 (press release, 1 June 2007).
12. US Food and Drug Administration. 21 CFR Part 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Final Rule. Federal Register 72, 34752-39958 (25 June 2007).
13. 21 CFR 111.70(b)(3).
14. US Food and Drug Administration. 21 CFR Part 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Final Rule. Federal Register 72, 34782 (25 June 2007).
15. 21 CFR 111.70 and 111.75.
16. 21 CFR 111, subpart F.
17. 21 CFR 111.610.
18. 21 CFR 101.36 and relevant sections of 21 CFR 101.4 and 101.9.
19. 21 CFR 101.93.